167 related articles for article (PubMed ID: 7233140)
1. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
Gasser AB; Jeannet C; Depierre D; Courvoisier B
Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
[TBL] [Abstract][Full Text] [Related]
2. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Rinsho K; Aoyagi K
Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
[TBL] [Abstract][Full Text] [Related]
3. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
[TBL] [Abstract][Full Text] [Related]
4. Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer.
Hopkins SC; Nissenkorn I; Palmieri GM; Ikard M; Moinuddin M; Soloway MS
J Urol; 1983 Feb; 129(2):319-23. PubMed ID: 6834497
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
[No Abstract] [Full Text] [Related]
6. Serum osteocalcin concentration in patients with prostatic cancer.
Francini G; Bigazzi S; Leone V; Gennari C
Am J Clin Oncol; 1988; 11 Suppl 2():S83-7. PubMed ID: 3266542
[TBL] [Abstract][Full Text] [Related]
7. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
8. Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
Bishop MC; Fellows GJ
Br J Urol; 1977; 49(7):711-6. PubMed ID: 597712
[TBL] [Abstract][Full Text] [Related]
9. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
Miyamoto KK; McSherry SA; Robins SP; Besterman JM; Mohler JL
J Urol; 1994 Apr; 151(4):909-13. PubMed ID: 7510346
[TBL] [Abstract][Full Text] [Related]
10. [Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer (II): Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and tumor markers in blood and urine].
Nemoto S; Rinsho K
Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):53-8. PubMed ID: 6539837
[No Abstract] [Full Text] [Related]
11. Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases.
Heller W; Harzmann R; Bichler KH; Schmidt K
Curr Probl Clin Biochem; 1979; (9):249-56. PubMed ID: 446076
[TBL] [Abstract][Full Text] [Related]
12. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
13. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Cuschieri A
Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
[No Abstract] [Full Text] [Related]
14. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
Broulik PD; Stĕpán JJ; Límanová Z; Pacovský V
Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
[TBL] [Abstract][Full Text] [Related]
15. Use of urinary hydroxyproline excretion as a tumor marker in diagnosis and follow-up of prostatic carcinoma.
Unni Mooppan MM; Kim H; Wang JC; Tobin MS; Wax SH
Prostate; 1983; 4(4):397-405. PubMed ID: 6191318
[TBL] [Abstract][Full Text] [Related]
16. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
17. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
[TBL] [Abstract][Full Text] [Related]
18. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
Broulik PD; Stĕpán J; Pacovský V
Exp Clin Endocrinol; 1984 May; 83(3):315-9. PubMed ID: 6540700
[TBL] [Abstract][Full Text] [Related]
19. [Early detection of bone metastases in carcinoma of the prostate using the gamma camera].
Flores Corral N; Unda M; Jorge A; Arregui R; Prieto N
Arch Esp Urol; 1985; 38(2):131-6. PubMed ID: 4026394
[No Abstract] [Full Text] [Related]
20. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]